Vordermeier H M, Harris D P, Moreno C, Ivanyi J
MRC Clinical Sciences Centre, Tuberculosis and Related Infections Unit, Hammersmith Hospital, London, GB.
Eur J Immunol. 1994 Sep;24(9):2061-7. doi: 10.1002/eji.1830240919.
Genetically permissive T cell epitopes are an important prerequisite for the development of peptide-based vaccines or immunodiagnostic reagents. We have investigated the structural requirements of permissive T cell recognition of peptide p350-369 from the 38-kDa antigen of Mycobacterium tuberculosis. This peptide was found to be immunogenic in mice of the H-2b, bm12, d, s and k, but not of the H-2f genotype. T cell responses were restricted by I-A class II molecules. The same epitope core was recognized in the H-2b, d and k genotypes. T cell hybrids from BALB/c and C57BL/10 mice were used to determine: (i) the critical residues using substituted peptide derivatives and (ii) the degree of T cell promiscuity. Two out of five BALB/c (H-2d)-derived hybridomas tested displayed promiscuous peptide recognition in the context of H-2b and H-2bm12 antigen-presenting cells. The recognition of critical residues was found to be uniform for all five hybridomas when tested with syngeneic antigen-presenting cells; additional critical residues were identified when the peptide was recognized in the context of allogeneic antigen-presenting cells. Only one of the four tested C57BL/10 (H-2b) hybridomas showed promiscuity in the context of H-2bm12. Each of these C57BL/10-derived clones had a distinct response profile toward the critical residues. We propose that the demonstrated T cell promiscuity involves peptide interaction with polymorphic H-2 I-A residues.
基因允许性T细胞表位是基于肽的疫苗或免疫诊断试剂开发的重要前提条件。我们研究了结核分枝杆菌38 kDa抗原中肽p350 - 369的允许性T细胞识别的结构要求。发现该肽在H - 2b、bm12、d、s和k基因型的小鼠中具有免疫原性,但在H - 2f基因型的小鼠中则不然。T细胞反应受II类I - A分子限制。在H - 2b、d和k基因型中识别到相同的表位核心。使用来自BALB/c和C57BL/10小鼠的T细胞杂交瘤来确定:(i) 使用取代肽衍生物确定关键残基,以及(ii) T细胞混杂程度。测试的五个源自BALB/c(H - 2d)的杂交瘤中有两个在H - 2b和H - 2bm12抗原呈递细胞的背景下表现出混杂的肽识别。当用同基因抗原呈递细胞测试时,发现所有五个杂交瘤对关键残基的识别是一致的;当在异基因抗原呈递细胞的背景下识别该肽时,鉴定出了额外的关键残基。测试的四个源自C57BL/10(H - 2b)的杂交瘤中只有一个在H - 2bm12的背景下表现出混杂性。这些源自C57BL/10的每个克隆对关键残基都有不同的反应谱。我们提出所证明的T细胞混杂涉及肽与多态性H - 2 I - A残基的相互作用。